Avedro Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Avedro Inc (AVDR) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Avedro Inc vs Its Competitors
- Peer revenue share: Avedro Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
AVDR Sales vs. its Competitors, Q3 2019
Avedro Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
API endpoints for this dataset
For context: the Major Pharmaceutical Preparations industry grew revenue 8.9% year over year, combined, vs 37.8% for Avedro Inc. Avedro Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.
Avedro Inc's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Avedro Inc | - | - | - | Yes |
| High-Confidence Competitors (5) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
AVDR Stock Performance relative to its Competitors
AVDR Stock Performance relative to High-Confidence Competitors
Avedro Inc's Competitors Named by the Company
Competitive relationships identified from Avedro Inc reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Sight Sciences | Company report | 85% |
| AbbVie Inc. | Company report | 85% |
| Alcon | Company report | 85% |
| Lenz Therapeutics Inc | Company report | 85% |
| Spyglass Pharma Inc | Company report | 85% |
| Ivantis Inc. | Company report | 85% |
| New World Medical | Company report | 85% |
| Novartis Ag | Company report | 85% |
| Aerie Pharmaceuticals Inc | Company report | 85% |
| Eyepoint Inc | Company report | 85% |
Company report basis, confidence, active dates and source counts for Avedro Inc's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.